Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.

MLA

Ju, Melody, et al. “Application of a Telomerase-Based Circulating Tumor Cell (CTC) Assay in Bladder Cancer Patients Receiving Postoperative Radiation Therapy: A Case Study.” Cancer Biology & Therapy, vol. 15, no. 6, June 2014, pp. 683–87. EBSCOhost, https://doi.org/10.4161/cbt.28412.

APA

Ju, M., Kao, G. D., Steinmetz, D., Chandrasekaran, S., Keefe, S. M., Guzzo, T. J., Christodouleas, J. P., Hahn, S. M., & Dorsey, J. F. (2014). Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study. Cancer Biology & Therapy, 15(6), 683–687. https://doi.org/10.4161/cbt.28412

Chicago

Ju, Melody, Gary D Kao, David Steinmetz, Sanjay Chandrasekaran, Stephen M Keefe, Thomas J Guzzo, John P Christodouleas, Stephen M Hahn, and Jay F Dorsey. 2014. “Application of a Telomerase-Based Circulating Tumor Cell (CTC) Assay in Bladder Cancer Patients Receiving Postoperative Radiation Therapy: A Case Study.” Cancer Biology & Therapy 15 (6): 683–87. doi:10.4161/cbt.28412.